Abstract
Bechterew’s syndrome was used to explain the classic and old manifestation of ankylosing spondylitis (AS) and spondyloarthropathy (SpA) and also is much more generally used among German medical communities. Despite primary clinical and anatomical descriptions of AS indicating it was a distinct disease, the concept underlying AS developed over time with the development of roentgenology and other medical and scientific advances (Von Bechterew 1893; Strümpell 1897; Sieper et al. 2002). AS is a heterogeneous group and seronegative inflammatory of rheumatologic diseases with widely known genetic and clinical characteristics. The AS is categorized as axial or peripheral depending on the most vulnerable regions of the human system (Hamsen et al. 2018; Zhu et al. 2019). A specific kind of general term called spondyloarthropathies is AS, known almost as an autoimmune disease mostly affecting the sacroiliac joints (SIJs), spine joints, and surrounding soft tissues, including ligaments and tendons. During the late stages of the disease, this inflammation might result in calcification and fibrosis, leading to a spine fusion and reduced flexibility, looking like “bamboo” in such a motionless posture. A specific pain localized in the lower back, gradual rigidity in the spine, and inflammation flared up in the hip, peripheral joints (toes/fingers), and shoulders seem to be the most common clinical signs and symptoms. Inflammatory bowel disease (IBD) and acute anterior uveitis are two common extraarticular manifestations (Lindström et al. 2018; Moltó and Nikiphorou 2018).
References
Abbood HM, Pathan E, Cherukara GP (2018) The link between ankylosing spondylitis and oral health conditions: two nested case-control studies using data of the UK Biobank. J Appl Oral Sci 27:e20180207
Arévalo M, Gratacós Masmitjà J, Moreno M, Calvet J, Orellana C, Ruiz D, Castro C, Carreto P, Larrosa M, Collantes E, Font P (2018) Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database. Arthritis Res Ther 20(1):221
Arvikar SL, Fisher MC (2011) Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med 4(3):123–131
Bentaleb I, Abdelghani KB, Rostom S, Amine B, Laatar A, Bahiri R (2020) Reactive arthritis: update. Curr Clin Microbiol Rep 7(4):124–132
Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379–1390
Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. Lancet 1(7809):904–907
Brown MA (2010) Genetics of ankylosing spondylitis. Curr Opin Rheumatol 22(2):126–132
Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, Taylor A, Calin A, Wordsworth P (1997) Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40(10):1823–1828
Brunner F, Kunz A, Weber U, Kissling R (2006) Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol 25(1):24–29
Cairns AP, Wright SA, Taggart AJ, Coward SM, Wright GD (2005) An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover. Ann Rheum Dis 64(2):338–339
Calin A, Dijkmans BA, Emery P, Hakala M, Kalden J, Leirisalo-Repo M, Mola EM, Salvarani C, Sanmartí R, Sany J, Sibilia J, Sieper J, van der Linden S, Veys E, Appel AM, Fatenejad S (2004) Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis 63(12):1594–1600
Chen J, Liu C (2005) Sulfasalazine for ankylosing spondylitis. Cochrane Database Syst Rev (2):Cd004800
Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 2008(1):Cd002822
Davis JC Jr, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W (2003) Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48(11):3230–3236
de Blecourt J, Polman A, de Blecourt-Meindersma (1961) Hereditary factors in rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 20(3):215–220
De Keyser F, Elewaut D, De Vos M, De Vlam K, Cuvelier C, Mielants H, Veys EM (1998) Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin N Am 24(4):785–813, ix–x
Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden S, Brandt J (2002) Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 61(Suppl 3):iii40–iii50
El Maghraoui A (2011) Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 22(6):554–560
Elewaut D, Matucci-Cerinic M (2009) Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice. Rheumatology (Oxford) 48(9):1029–1035
Erdem CZ, Sarikaya S, Erdem LO, Ozdolap S, Gundogdu S (2005) MR imaging features of foot involvement in ankylosing spondylitis. Eur J Radiol 53(1):110–119
Fan M, Liu J, Zhao B, Wu X, Li X, Gu J (2020) Indirect comparison of NSAIDs for ankylosing spondylitis: network meta-analysis of randomized, double-blinded, controlled trials. Exp Ther Med 19(4):3031–3041
Gladman DD (1998) Psoriatic arthritis. Rheum Dis Clin N Am 24(4):829–844. x
Golder V, Schachna L (2013) Ankylosing spondylitis: an update. Aust Fam Physician 42(11):780–784
Gomez-Simmonds A, Uhlemann AC (2017) Clinical implications of genomic adaptation and evolution of Carbapenem-Resistant Klebsiella pneumoniae. J Infect Dis 215(suppl_1):S18–s27
Gooren LJ, Giltay EJ, van Schaardenburg D, Dijkmans BA (2000) Gonadal and adrenal sex steroids in ankylosing spondylitis. Rheum Dis Clin N Am 26(4):969–987
Haibel H, Rudwaleit M, Brandt HC, Grozdanovic Z, Listing J, Kupper H, Braun J, Sieper J (2006) Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial. Arthritis Rheum 54(2):678–681
Hamsen U, Kamp O, Kaczmarek C, Aach M, Waydhas C, Schildhauer TA, Jansen O (2018) Percutaneous dilatational tracheostomy in ankylosing spondylitis (Bechterew disease) is feasible and not associated with higher complication rates. J Intensive Care Med 33(7):420–423
Klingberg E, Sveälv BG, Täng MS, Bech-Hanssen O, Forsblad-d’Elia H, Bergfeldt L (2015) Aortic regurgitation is common in ankylosing spondylitis: time for routine echocardiography evaluation? Am J Med 128(11):1244–1250.e1241
Kraag G, Stokes B, Groh J, Helewa A, Goldsmith C (1990) The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis – a randomized controlled trial. J Rheumatol 17(2):228–233
Lin H, Gong YZ (2017) Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis. Rheumatol Int 37(8):1267–1280
Lindström U, Olofsson T, Wedrén S, Qirjazo I, Askling J (2018) Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study. RMD Open 4(2):e000762
Malakar A, Kakati S, Barman B, Dutta A (2020) Clinical presentation and subtypes of spondyloarthritis patients in north East India. The Egyptian Rheumatologist 42(4):271–274
Moltó A, Nikiphorou E (2018) Comorbidities in Spondyloarthritis. Front Med (Lausanne) 5:62
Novelli L, Lubrano E, Venerito V, Perrotta FM, Marando F, Curradi G, Iannone F (2021) Extra-articular manifestations and comorbidities in psoriatic disease: a journey into the immunologic crosstalk. Front Med (Lausanne) 8:737079
Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB (1996) Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 98(4):945–953
Reveille JD (2006) The genetic basis of ankylosing spondylitis. Curr Opin Rheumatol 18(4):332–341
Reveille JD (2011) The genetic basis of spondyloarthritis. Ann Rheum Dis 70(Suppl 1):i44–i50
Rudwaleit M, Siegert S, Yin Z, Eick J, Thiel A, Radbruch A, Sieper J, Braun J (2001) Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 60(1):36–42
Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63(5):535–543
Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52(4):1000–1008
Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J (2009a) The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783
Rudwaleit M, Haibel H, Baraliakos X, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J (2009b) The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis inception cohort. Arthritis Rheum 60(3):717–727
Sieper J, Braun J, Kingsley GH (2000) Report on the fourth international workshop on reactive arthritis. Arthritis Rheum 43(4):720–734
Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(Suppl 3):iii8–ii18
Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A (2015) Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis 74(1):65–73
Strümpell A (1897) Bemerkung über die chronische ankylosirende Entzündung der Wirbelsäule und der Hüftgelenke. Dtsch Z Nervenheilkd 11:338–342
Tan S, Wang R, Ward MM (2015) Syndesmophyte growth in ankylosing spondylitis. Curr Opin Rheumatol 27(4):326–332
Tapia-Serrano R, Jimenez-Balderas FJ, Murrieta S, Bravo-Gatica C, Guerra R, Mintz G (1991) Testicular function in active ankylosing spondylitis. Therapeutic response to human chorionic gonadotrophin. J Rheumatol 18(6):841–848
Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernández-Sueiro JL, Balish E, Hammer RE (1994) The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 180(6):2359–2364
van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H, Davis JC Jr (2006) Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54(7):2136–2146
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368
van Hoeven L, Koes BW, Hazes JM, Weel AE (2015) Evaluating the ASAS recommendations for early referral of axial spondyloarthritis in patients with chronic low back pain; is one parameter present sufficient for primary care practice? Ann Rheum Dis 74(12):e68–e68
van Tubergen A (2015) The changing clinical picture and epidemiology of spondyloarthritis. Nat Rev Rheumatol 11(2):110–118
Von Bechterew W (1893) Steifigkeit der Wirbelsäule und ihre Verkrümmung als besondere Erkrankungsform. Neurologisches Zentralblatt 12:426–434
Wallman JK, Kapetanovic MC, Petersson IF, Geborek P, Kristensen LE (2015) Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients – baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice. Arthritis Res Ther 17:378
Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X, Qiu G, Cao X, Weng X (2019) Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res 7:22
Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, Dougados M, Géher P, Inman RD, Khan MA, Kvien TK, Leirisalo-Repo M, Olivieri I, Pavelka K, Sieper J, Stucki G, Sturrock RD, van der Linden S, Wendling D, Böhm H, van Royen BJ, Braun J (2006a) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65(4):442–452
Zochling J, van der Heijde D, Dougados M, Braun J (2006b) Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis 65(4):423–432
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 Crown
About this entry
Cite this entry
Bahrami, A., Mirghaderi, P. (2024). Bechterew’s Syndrome. In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_1401-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-66816-1_1401-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-66816-1
Online ISBN: 978-3-319-66816-1
eBook Packages: Springer Reference MedicineReference Module Medicine